Request Free Demo
"My patient had a history of post menopausal bleeding and had an abnormal Pap. The Pipelle came back with insufficient tissue. A D&C Hysteroscopy was done in the O.R., but that also came back with insufficient tissue. Lastly, I tried the Tao Brush and got a successful diagnosis off of cytology."
Marlo Carter M.D.
Women’s Wellness Healthcare Associates, Limerick, PA

MicroVysion – Hematuria Analysis

Gynecor is proud to be the first GYN laboratory to introduce MicroVysion®: the first-line test for the diagnosis and management of hematuria. The test includes a complete urine analysis to deliver a detailed site map showing from where the blood originated, and if infection or cancer may be present.

MicroVysion focuses on the origin of hematuria, specifying renal versus non-renal bleeding.

MicroVysion is also useful for the evaluation of:

  • Infections
  • Inflammatory conditions
  • Diseases of the kidney (including causes of dysmorphic hematuria)
  • Diabetes
  • Hypertension
  • Renal disease associated with lupus

Multiple Tests in One Kit

MicroVysion is made up of Morphology/Cytology and Chemistry. Reflexing to FISH is another option for further defining atypical or suspicious diagnoses. All parts can be run off the two vials provided in the MicroVysion kit.

Red Blood Cell Morphology

  • By looking at the shape of the red blood cells, our pathologist can determine where the blood originated
  • Morphology is run to help detect TCC indicating cancer
  • The entire urinary tract is examined, including the bladder, urethra, ureters and kidneys
  • Cells from morphology can be benign, atypical, suspicious, or malignant

Chemistry

  • Chemistry rules out bacterial infections such as a common urinary tract infection

FISH (Fluorescence In-Situ Hybridization)

  • FISH is run as a reflex off of atypical or suspicious urine cytology diagnoses
  • FISH allows the cells to be studied at a chromosomal level
  • FISH has a specificity of 97%, with a much higher sensitivity for urothelial carcinoma detection of 93% (versus cytology at 73%)*
  • Gynecor’s pathologists are highly trained to make these critical diagnoses

* Meiers I, Singh H, Hossian D, Lang K, Qian J, Verhest AP, Bostwick DG. Improved filter method for urine sediment detection of urothelial carcinoma by fluorescene in situ hybridization. Arch Pathol Lab Med. 2007;131(10):1574-7.